// App-Quantinova.ai

: Evidence-based consensus recommendations for the identification and management of interstitial lung disease in systemic sclerosis

Researchers

Presenter

  • Anna-Maria Hoffmann-Vold

Principal Investigators

  • Toby M Maher

  • Edward E Philpot

  • Ali Ashrafzadeh

  • Oliver Distler

  • Michael Kreuter

Medical Centers

  • Department of Oncology, Oslo University Hospital, Oslo, Norway

  • National Heart and Lung Institute, Imperial College London; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK, London, United Kingdom

  • Respiratory Center of Excellence, IQVIA, Durham, NC, United States of America

  • Rheumatology Center of Excellence, IQVIA, San Diego, CA, United States of America

  • Department of Neurology, University Hospital Zurich, Zurich, Switzerland

  • University Clinic Heidelberg, Heidelberg, Germany

Locations

  • Norway

  • United Kingdom

  • United States

  • Switzerland

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Scleroderma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved